Revenue Growth (Annual) score
Annual revenue growth tracks year-over-year sales expansion. Consistent double-digit growth earns higher scores, indicating strong market demand and competitive positioning.
How StocksScores scores it
Year-over-year revenue growth is computed for each consecutive pair of years, each capped between -75% and +300%. Up to the last 10 rates are averaged with exponential weights (1.5 to the power of the year index), so the latest year counts far more than older ones. Scored against a sector band where higher is better: a value at the band's floor scores about 35, at its ceiling about 95, linear in between; half a band-width below the floor scores about 5, and beyond either end the score keeps easing toward 0 or 100 instead of clipping. The band is picked by industry first (consumer electronics, semiconductors, grocery and discount retail have their own), then by sector, else a general default. Example with the default band (-2% to 20%): 10% weighted growth scores about 68, 20% about 95; the Technology band is 0% to 100%, so 10% growth there scores only about 41. For banks, whose statements carry no revenue line, revenue is taken as net interest income plus non-interest income.
Data: Annual income statements from Finnhub (up to about 10 years of revenue).
Not scored when: Fewer than two years with positive revenue.
Weight in the stock score
It carries 5% of the fundamental pillar's weight (4 of 84). The fundamental total is then ranked within the company's sector, and that pillar is 80% of the composite score.
The full method — timeframes, the sector ranking and how missing data is handled — is on how the stock score works. For the metric itself, read Growth Investing: How to Identify High-Growth Stocks Early.
Revenue Growth (Annual) across US stocks today
2,304 US companies worth $1B or more have a Revenue Growth (Annual) reading as of Nov 19, 2026; the median scores 62.
- Bearish · 0–39
- 204
- Weak · 40–49
- 367
- Neutral · 50–65
- 744
- Bullish · 66–79
- 360
- Very bullish · 80–100
- 629
Median by sector
| Sector | Stocks | Median |
|---|---|---|
| Utilities | 76 | 84 |
| Real Estate | 119 | 72 |
| Financial Services | 415 | 65 |
| Healthcare | 302 | 65 |
| Energy | 147 | 65 |
| Industrials | 312 | 65 |
| Basic Materials | 121 | 63 |
| Consumer Defensive | 103 | 62 |
| Consumer Cyclical | 252 | 61 |
| Communication Services | 102 | 57 |
| Technology | 355 | 46 |
Highest Revenue Growth (Annual) scores
| Company | Sector | Market cap | Score |
|---|---|---|---|
| BAM Brookfield Asset Management | Financial Services | $80.2B | 100 |
| APO Apollo Global Management | Financial Services | $68.7B | 100 |
| HOOD Robinhood Markets | Financial Services | $61.8B | 100 |
| ARGX argenx | Healthcare | $59.2B | 100 |
| NU Nu Holdings | Financial Services | $57.2B | 100 |
| RKLB Rocket Lab | Industrials | $34.3B | 100 |
| NBIS Nebius Group | Communication Services | $28.4B | 100 |
| SYM Symbotic | Industrials | $20.1B | 100 |
| ASND Ascendis Pharma A/S | Healthcare | $16.8B | 100 |
| BBIO BridgeBio Pharma | Healthcare | $15.2B | 100 |
| NLY Annaly Capital Management | Real Estate | $13.4B | 100 |
| FUTU Futu Holdings | Financial Services | $12.2B | 100 |
| QXO QXO | Industrials | $11.5B | 100 |
| IONQ IonQ | Technology | $10.5B | 100 |
| AGNC AGNC Investment | Real Estate | $10.0B | 100 |
| TGTX TG Therapeutics | Healthcare | $9.8B | 100 |
| BMNR Bitmine Immersion Technologies | Financial Services | $9.4B | 100 |
| KRYS Krystal Biotech | Healthcare | $9.4B | 100 |
| MDGL Madrigal Pharmaceuticals | Healthcare | $9.2B | 100 |
| XPEV XPeng | Consumer Cyclical | $9.0B | 100 |
Lowest Revenue Growth (Annual) scores
| Company | Sector | Market cap | Score |
|---|---|---|---|
| PLSE Pulse Biosciences | Healthcare | $3.3B | 1 |
| SFNC Simmons First National | Financial Services | $3.2B | 2 |
| IMNM Immunome | Healthcare | $2.0B | 3 |
| SWX Southwest Gas | Utilities | $6.5B | 3 |
| ROIV Roivant Sciences | Healthcare | $28.2B | 3 |
| RYN Rayonier | Real Estate | $6.1B | 4 |
| OPK OPKO Health | Healthcare | $1.2B | 5 |
| NWL Newell Brands | Consumer Defensive | $2.3B | 5 |
| ENIC Enel Chile | Utilities | $5.5B | 5 |
| RVMD Revolution Medicines | Healthcare | $34.5B | 5 |
One scorer is one input among many, not a recommendation. Each company’s page shows every scorer behind its composite.